Skip to content

Author

Mark Woodward

We have 4 of 67 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Comorbidity, Frailty, and Glycaemic Control Among Older Patients with Diabetes: A Multi-Centre Study in Vietnam

There was a high burden of comorbidity and frailty among the participants, and frailty was associated with greater odds of poor glycaemic control, and Routine assessment of frailty is essential in managing long-term diabetes.

W. Wong, Tan van Nguyen, D. Truong et al. · 0 citations
Open access Sep 2026

Distribution of Cardiovascular Disease Risk Based on the Updated 2023 Guideline‐Recommended Australian Cardiovascular Disease Risk Algorithm and Comparison With the 2012 Algorithm: An Observational Study

ABSTRACT Objectives To quantify cardiovascular disease (CVD) risk, and implications for targeting preventive pharmacotherapy, using the 2023 guideline‐recommended Australian CVD risk algorithm, and compare this to the previous (2012) algorithm. Study Type Application and comparison of two risk prediction algorithms. Se...

N. Lazarevic, M. Bhat, Grace Joshy et al. · 0 citations
Sep 2026

Circulating Metabolites Are Biomarker Candidates for Stroke Risk Prediction: Results From the BiomarCaRE Project.

Six metabolites from 4 different metabolite classes that were associated with future risk of stroke were identified, and the application of specific circulating metabolites may improve early stroke risk prediction before the onset of potentially irreversible cerebrovascular pathological processes.

C. Schulte, Francisco M. Ojeda, Märit Jensen et al. · 0 citations
Open access Aug 2026

Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study

This investigation investigated whether selective integration of lipidomic and genomic risk signals into AusCVDRisk improves 5-year CVD prediction and reclassification, with a focus on individuals at intermediate clinical risk.

Aleksandar Dakic, Jing-Qin Wu, Ting-Ting Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.